Literature DB >> 2762557

Levuglandin E2 crosslinks proteins.

R S Iyer1, S Ghosh, R G Salomon.   

Abstract

Levuglandin E2 (LGE2), a gamma-ketoaldehyde produced by rearrangement of the prostaglandin endoperoxide PGH2 under the aqueous conditions of its biosynthesis, causes extensive intermolecular crosslinking of ovalbumin at pH 6 or pH 7 and 37 degrees C. The time dependence of protein oligomerization is monitored by SDS-PAGE. Effects of pH and concentration on the extent of LGE2-induced crosslinking are examined. The efficacy of LGE2 for inducing crosslinking is compared with other oxidative metabolites of arachidonic acid (AA), including the prostaglandins PGE2, PGD2, PGA2, PGB2, and PGF2 alpha, as well as malondialdehyde and E-4-hydroxy-non-2-enal. LGE2 is orders of magnitude more effective in crosslinking protein than any other cyclooxygenase or lipoxygenase metabolite of AA tested.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2762557     DOI: 10.1016/0090-6980(89)90096-8

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  29 in total

1.  Total Synthesis Confirms the Molecular Structure Proposed for Oxidized Levuglandin D2.

Authors:  Yu-Shiuan Cheng; Wenyuan Yu; Yunfeng Xu; Robert G Salomon
Journal:  J Nat Prod       Date:  2017-02-14       Impact factor: 4.050

2.  PGH2-derived levuglandin adducts increase the neurotoxicity of amyloid beta1-42.

Authors:  Olivier Boutaud; Thomas J Montine; Lei Chang; William L Klein; John A Oates
Journal:  J Neurochem       Date:  2006-01-12       Impact factor: 5.372

3.  Pyridoxamine analogues scavenge lipid-derived gamma-ketoaldehydes and protect against H2O2-mediated cytotoxicity.

Authors:  Sean S Davies; Eric J Brantley; Paul A Voziyan; Venkataraman Amarnath; Irene Zagol-Ikapitte; Olivier Boutaud; Billy G Hudson; John A Oates; L Jackson Roberts
Journal:  Biochemistry       Date:  2006-12-06       Impact factor: 3.162

Review 4.  Covalent modification of biological targets with natural products through Paal-Knorr pyrrole formation.

Authors:  Alexander Kornienko; James J La Clair
Journal:  Nat Prod Rep       Date:  2017-08-30       Impact factor: 13.423

5.  Isolevuglandins as a gauge of lipid peroxidation in human tumors.

Authors:  H P Yan; L J Roberts; S S Davies; P Pohlmann; F F Parl; S Estes; J Maeng; B Parker; R Mernaugh
Journal:  Free Radic Biol Med       Date:  2017-02-09       Impact factor: 7.376

6.  Determination of 3-methoxysalicylamine levels in mouse plasma and tissue by liquid chromatography-tandem mass spectrometry: application to in vivo pharmacokinetics studies.

Authors:  Irene Zagol-Ikapitte; Venkataraman Amarnath; Satyawan Jadhav; John A Oates; Olivier Boutaud
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2011-03-21       Impact factor: 3.205

Review 7.  Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension.

Authors:  Liang Xiao; David M Patrick; Luul A Aden; Annet Kirabo
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-09-29       Impact factor: 3.072

8.  Isoketals form cytotoxic phosphatidylethanolamine adducts in cells.

Authors:  C Blake Sullivan; Elena Matafonova; L Jackson Roberts; Venkataraman Amarnath; Sean S Davies
Journal:  J Lipid Res       Date:  2009-11-25       Impact factor: 5.922

Review 9.  Neuroprotection in glaucoma using calpain-1 inhibitors: regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therapeutics.

Authors:  Bharathi Govindarajan; James Laird; Ronald Sherman; Robert G Salomon; Sanjoy K Bhattacharya
Journal:  CNS Neurol Disord Drug Targets       Date:  2008-06       Impact factor: 4.388

10.  Posttranslational modification by an isolevuglandin diminishes activity of the mitochondrial cytochrome P450 27A1.

Authors:  Casey D Charvet; James Laird; Yunfeng Xu; Robert G Salomon; Irina A Pikuleva
Journal:  J Lipid Res       Date:  2013-03-11       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.